Magazine Store

50 Leading Companies of the Year 2017

A Disruptive and Diverse Scientific Agency Dedicated To Serving the Healthcare Sector: Simpson Healthcare Executives

thesiliconreview-kelly-simpson-angelini-ceo-simpson-healthcare-executives-17Simpson Healthcare Executives is an award-winning scientific agency, with a unique ability to be a disruptive and transformative catalyst for innovation within the ever-evolving healthcare industry. Driven by the purpose to support its clients in sharing the scientific story of the diseases they touch and therapies they discover for all in need, Simpson Healthcare challenges key stakeholders in healthcare to think disruptively about the future of healthcare as the agency unlocks their full potential to most positively impact patients who could benefit most from their therapies.

The Simpson Healthcare team is very passionate about their work and how their work contributes to the healthcare field. The agency discovers and delivers what patients really want. The real value of healthcare comes from Simpson Healthcare’s ability to grow its clients’ brands by delivering real value for patients. Recently, the agency pioneered the creation of future health forums, where world experts unite to explore global datasets, shifts, health policies, and patient needs for the coming years.

Simpson Healthcare: Traditional Transformative Innovative

Simpson Healthcare Executives was founded in 1998, as a scientific marketing and communications agency serving the healthcare sector. Founded by Kelly Simpson-Angelini, Simpson Healthcare develops the scientific narrative of why its clients’ brands matter for patients and deliver the story that the clients need to tell. The agency achieves this through a broad array of collaborative marketing platforms and modern day scientific story-telling, always keeping the patient experience at the center of its focus.

Headquartered in Connecticut, the agency’s rich heritage and transformative solutions have ushered the company to a significant growth. Simpson Healthcare recently launched a new line of FUTURING work with its big Pharma Clients. The agency envisioned the potential best and worst futures without any reference to present day. Once the Futures have been imagined, the drivers to reach those futures are identified, which help to pinpoint opportunities to shape a “Desired Future,” or avoid impact from an “Undesirable Future.” The reason this work is important is that the purpose of Futuring is to look at global datasets, policies, and influential variables, and to disrupt key markets in healthcare with a longer 10-20-year vision for the future. “Our work here has been launched with our top clients, and many others, who are disruptively transforming healthcare in the industry,” says Simpson-Angelini.

Connecting the Science of the Present with the Discoveries of the Future

Simpson Healthcare has some of the brightest minds in science, business, and technology and its highly collaborative internal teams are central to the organization. The firm’s transformative, innovative, and wise senior leaders manage and develop its people and are led by founder, Kelly Simpson-Angelini, who is a role model for entrepreneurs and executives across the globe. “Our people are the link connecting the science of the present with the discoveries of the future, and we transform the healthcare experience and build upon the healthcare landscape together with our biopharmaceutical clients for the next generations to come.” Say Simpson-Angelini.

The firm’s senior leadership team excels in the management of people and ensures that Simpson Healthcare has the right people on every team to best support its healthcare clients and their goals. “We ensure that our teams are well-balanced and well-equipped with all of the resources that we need to be successful, always looking and listening to collaboratively develop and implement new systems and processes that drive learnings, effectiveness, and efficiencies within the agency,” adds Simpson-Angelini.

The Simpson’s team listens and looks beyond next year and into the next decades to understand how the greater healthcare landscape works and the agency collaboratively develop new scientific communication methods and marketing platforms that best support its clients’ needs and position them to achieve the best possible outcomes for their therapeutic brands that are most impactful for patients.

Pillars of Strength: Simpson’s Core Values 

Kelly Simpson-Angelini talks about the company’s greatest assets and how it is bringing out the people in her employees.

Simpson Healthcare is guided by five core values that all team members believe in and live by in alignment with our purpose. These five values guide our internal teams in our knowledge, in our interactions, and build the core foundational beliefs of our culture that keep us moving forward to make our connections with each of our clients, with each other, and with the greater healthcare system both impactful and meaningful as we strive to support our clients in helping patients across the globe to live better.

We embrace the core values at Simpson Healthcare: we maintain passion about making a difference by pushing the boundaries to create unique strategic value for our company, our clients, and our community; keeping it real by developing strong, authentic relationships internally and externally with our clients; looking to the future by never losing sight of the larger context and bigger opportunity; knowing we are better together and dedicated to collaborative teamwork to ensure the highest quality work product; and finally, we bring our best selves to work every day, which means we are committed to achieving personal balance and strength, both at work, and in our own lives.

Vision for the Future

The core stories of disease, diagnosis, and new therapies will continue to be unknown and abundant. The agency sees huge opportunity to continue to build knowledge and skills in organizing and showcasing scientific content. Simpson-Angelini reveals “We will have more brands to build; more ways to build them and explain them. We believe we will be supporting new types of products like gene therapies that are a simple once in a lifetime treatment.”

Simpson Healthcare will focus on a personalized and individualized approach to disease education and “my brand.” Simpson Healthcare is proud to unite and support its clients, to shape the future of healthcare so that the best therapeutic treatments may be available to provide a brighter health outlook for those in need.

Panegyrize the Game Changer

Kelly Simpson-Angelini, CEO, and CSO:  Simpson-Angelini began her career as a Research Scientist at Pfizer in the 80s and soon developed a passion for science and penchant for scientific storytelling. It was soon after that she founded Simpson Healthcare Executives.  Simpson-Angelini takes an active role in mentoring and coaching women, internally and externally, and in 2016, she was named a Women of Innovation Honoree by the Connecticut Technology Council for her entrepreneurial vision and leadership. She has since been honored in New York City by Medical Marketing and Media (MM&M) as a 2017 Healthcare Transformers- Top 10 Innovation Catalyst; and by Business Worldwide Magazine as 2017 Healthcare Industry CEO of the Year- the USA and 2017 Most Innovative CEO of the Year-USA at the 2017 Business Worldwide CEO Awards. Simpson-Angelini was honored most recently this fall at the 2017 Stevie Awards for Women in Business, where she won Female Entrepreneur of the Year-Business Services: 11-2,500 Employees, Company of the Year: More than 10 Employees, and Most Innovative Company of the Year: More than 10 Employees. Simpson-Angelini currently serves as Chair of the Board of Directors at Can Do Multiple Sclerosis (MS), a non-profit organization that was founded by the Olympic skier, Jimmie Huega in 1984, with a purpose of helping people with multiple sclerosis live better.

"Our goal is to support our clients and the healthcare system in the successful delivery of precision medicine to patients as we strive to connect the right patient with the right therapy at the right time to promote the best quality of life for those in need."